Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 1, 2025
Clinicopathological
correlations
differ
by
sex
in
Lewy
body
dementia
(LBD).
However,
previous
studies
have
focused
on
pathological
staging
systems
that
place
less
emphasis
regional
pathologies.
We
included
357
people
(131
female,
226
male)
with
a
high
likelihood
of
LBD
based
pathology
from
the
Brain
Bank
for
Neurodegenerative
(Jacksonville,
FL).
Sex
differences
body,
senile
plaque,
and
neurofibrillary
tangle
counts
their
associations
clinical
diagnosis
were
assessed.
Females
likely
to
diagnosis;
they
had
more
bodies,
tangles,
plaques
various
regions
than
males
(all
p's
<
0.05).
A
higher
was
associated
middle
frontal,
cingulate,
entorhinal
pathology,
so
females
0.045).
clinicopathological
also
occur
at
level.
frequency
misdiagnosis
males.
risk
underdiagnosis
(LBD)
males.Regional
LBD.Regional
association
differs
sex.Regional
stronger
phenotype
Language: Английский
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson’s disease
Acta Neuropathologica,
Journal Year:
2025,
Volume and Issue:
149(1)
Published: May 2, 2025
Language: Английский
14–3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity
Neurobiology of Disease,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106801 - 106801
Published: Jan. 1, 2025
Aggregation
of
alpha-synuclein
(αsyn)
plays
an
integral
role
in
Parkinson's
disease
(PD)
and
Dementia
with
Lewy
bodies
(DLB).
14-3-3θ
is
a
highly
expressed
brain
protein
chaperone-like
activity
that
regulates
αsyn
folding.
overexpression
reduces
aggregation,
transmission
between
cells,
neuronal
loss,
while
14-3-3
inhibition
promotes
pathology.
We
previously
observed
increased
phosphorylation
at
serine
232
human
PD
DLB
brains.
Here
we
examine
phosphorylation's
effects
on
aggregation
toxicity.
Using
paracrine
model,
found
the
non-phosphorylatable
S232A
protected
phosphomimetic
S232D
failed
to
protect
against
The
mutant
reduced
oligomerization
released
did
not.
showed
significant
reduction
binding
compared
wildtype
or
14-3-3θ.
knock-in
mouse
models
expressing
mutation
cortex
hippocampus,
examined
impact
S232
preformed
fibril
(PFF)
model.
Primary
neurons
from
mice
inclusion
formation
Cre
control
upon
PFF
treatment.
In
contrast,
inclusions.
αSyn
injection
into
dorsolateral
striatum
induced
higher
numbers
sensorimotor
mice.
conclusion,
interrupts
ability
bind
regulate
aggregation.
Increased
likely
accelerates
neurodegeneration
these
disorders.
Language: Английский